Ondansetron is a selective 5‑HT₃ receptor antagonist that blocks serotonin‑mediated activation of the chemoreceptor trigger zone and vagal afferents, preventing chemotherapy‑ and postoperative‑induced nausea and vomit...
Open this topic in Core Concepts